Letter to the Editor

King A Armstrong D. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing. J Diabetes Sci Technol. 2007; 1 (1): 36–41.

King A Armstrong D. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Bolus dosing. J Diabetes Sci Technol. 2007; 1 (1): 42–6.

Analysis of 541 insulin pumps used across the U.S., to be published by J Walsh, D Wroblewski, and T Bailey.

Table 3 in Apidra product handout, Rev. April 2004a.

Garg SK Rosenstock J Ways K. Optimized basal-bolus regimens in type 1 diabetes: Insuin glulisine versus regular human insulin in combination with basal insulin glargine. Endocr Pract. 2005; 11 (1): 11–7.

Scheiner G Boyer BA , Characteristics of basal insulin requirement by age and gender in Type-1 diabetes patients using insulin pump therapy. Diabetes Res Clin Pract. 2005; 69: 14–21.

Walsh J Roberts R. Pumping insulin. 4th ed. San Diego: Torrey Pines Press; 2006. p. 132.

De Feo P Perriello G Ventura MM Calcinaro F Basta G Lolli C Cruciani C Dell'Olio A Santeusanio F Brunetti P , Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: Relevance of the dawn phenomenon. Diabetologia. 1986; 29 (8): 475–80.

Garg S Chen Y Souhami E. Reduction in insulin dose and body weight with pre- and post-meal insulin glulisine (GLU) versus human regular insulin (RHI) in patients with type 1 diabetes. Diabetes. 2004; 53 (2): A119.

Diabetes Research in Children Network (DIRECNET) Study Group. The accuracy of the CGMS in children with type 1 diabetes: Results of the Diabetes Research in Children Network (DirecNet). Diabetes Technol Ther. 2003; 5: 781–9.